Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0OO6A
|
|||
Former ID |
DIB005350
|
|||
Drug Name |
Isbogrel
|
|||
Synonyms |
Antexan; A-66900; CV-4151
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Angina pectoris [ICD-11: BA40; ICD-9: 413] | Discontinued in Preregistration | [1] | |
Company |
Takeda Pharmaceutical Co Ltd
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H19NO2
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C(=CCCCCC(=O)O)C2=CN=CC=C2
|
|||
InChI |
1S/C18H19NO2/c20-18(21)12-6-2-5-11-17(15-8-3-1-4-9-15)16-10-7-13-19-14-16/h1,3-4,7-11,13-14H,2,5-6,12H2,(H,20,21)/b17-11+
|
|||
InChIKey |
UWPBQLKEHGGKKD-GZTJUZNOSA-N
|
|||
CAS Number |
CAS 89667-40-3
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Isomerase unspecific (IsoM) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000413) | |||
REF 2 | Beneficial effect of CV-4151 (Isbogrel), a thromboxane A2 synthase inhibitor, in a rat middle cerebral artery thrombosis model. Thromb Res. 1995 Jul 1;79(1):95-107. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.